• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ACUMED, LLC; PLATE, FIXATION, BONE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ACUMED, LLC; PLATE, FIXATION, BONE Back to Search Results
Device Problem Insufficient Information (3190)
Patient Problem Insufficient Information (4580)
Event Type  Injury  
Manufacturer Narrative
Manufacturing and inspection records could not be reviewed as device model number and batch/lot number is unknown.The device was not received for evaluation.Based on the information received, the root cause could not be determined.Related reports: 3025141-2023-00138, 3025141-2023-00139, 3025141-2023-00140, 3025141-2023-00141, 3025141-2023-00142, 3025141-2023-00143, 3025141-2023-00144, 3025141-2023-00145, 3025141-2023-00146, 3025141-2023-00147, 3025141-2023-00148, 3025141-2023-00149, 3025141-2023-00150, 3025141-2023-00151, 3025141-2023-00152, 3025141-2023-00153, 3025141-2023-00154, 3025141-2023-00155, 3025141-2023-00156, 3025141-2023-00157, 3025141-2023-00158, 3025141-2023-00159, 3025141-2023-00160, 3025141-2023-00161, 3025141-2023-00162, 3025141-2023-00163, 3025141-2023-00164, 3025141-2023-00165, 3025141-2023-00166, 3025141-2023-00167, 3025141-2023-00168, 3025141-2023-00169, 3025141-2023-00170, 3025141-2023-00171, 3025141-2023-00172, 3025141-2023-00173, 3025141-2023-00174, 3025141-2023-00175, 3025141-2023-00176, 3025141-2023-00177, 3025141-2023-00178, 3025141-2023-00179, 3025141-2023-00180, 3025141-2023-00181, 3025141-2023-00182, 3025141-2023-00183, 3025141-2023-00184, 3025141-2023-00185, 3025141-2023-00186, 3025141-2023-00187, 3025141-2023-00188, 3025141-2023-00189, 3025141-2023-00190, 3025141-2023-00191, 3025141-2023-00192, 3025141-2023-00193, 3025141-2023-00194, 3025141-2023-00195, 3025141-2023-00196, 3025141-2023-00197, 3025141-2023-00198, 3025141-2023-00199, 3025141-2023-00200, 3025141-2023-00201, 3025141-2023-00202, 3025141-2023-00203, 3025141-2023-00204, 3025141-2023-00205, 3025141-2023-00206, 3025141-2023-00207, 3025141-2023-00208, 3025141-2023-00209, 3025141-2023-00210, 3025141-2023-00211, 3025141-2023-00212, 3025141-2023-00213, 3025141-2023-00214, 3025141-2023-00215, 3025141-2023-00216, 3025141-2023-00217, 3025141-2023-00218, 3025141-2023-00219, 3025141-2023-00220, 3025141-2023-00221, 3025141-2023-00222, 3025141-2023-00223, 3025141-2023-00224, 3025141-2023-00225, 3025141-2023-00226, 3025141-2023-00227, 3025141-2023-00228, 3025141-2023-00229, 3025141-2023-00230, 3025141-2023-00231, 3025141-2023-00232, 3025141-2023-00233, 3025141-2023-00234, 3025141-2023-00235, 3025141-2023-00236, 3025141-2023-00237, 3025141-2023-00238, 3025141-2023-00239, 3025141-2023-00240, 3025141-2023-00241, 3025141-2023-00242, 3025141-2023-00244, 3025141-2023-00245, 3025141-2023-00246, 3025141-2023-00247, 3025141-2023-00248, 3025141-2023-00249, 3025141-2023-00250, 3025141-2023-00251, 3025141-2023-00252, 3025141-2023-00253, 3025141-2023-00254, 3025141-2023-00255, 3025141-2023-00256, 3025141-2023-00257, 3025141-2023-00258, 3025141-2023-00259, 3025141-2023-00260, 3025141-2023-00261, 3025141-2023-00262, 3025141-2023-00263, 3025141-2023-00264, 3025141-2023-00265, 3025141-2023-00266, 3025141-2023-00267, 3025141-2023-00268, 3025141-2023-00269, 3025141-2023-00270, 3025141-2023-00271, 3025141-2023-00272, 3025141-2023-00273, 3025141-2023-00274, 3025141-2023-00275, 3025141-2023-00276, 3025141-2023-00277, 3025141-2023-00278, 3025141-2023-00279, 3025141-2023-00280, 3025141-2023-00281, 3025141-2023-00282, 3025141-2023-00283, 3025141-2023-00284, 3025141-2023-00285, 3025141-2023-00286, 3025141-2023-00287, 3025141-2023-00288, 3025141-2023-00289, 3025141-2023-00290, 3025141-2023-00291, 3025141-2023-00292, 3025141-2023-00293, 3025141-2023-00294, and 3025141-2023-00295.
 
Event Description
The authors performed a retrospective single-center review of adult distal radius fracture patients treated with a volar locking plate between 2009 and 2019.In total, 2779 patients were included in the study.The primary outcome was a flexor tendon issue (flexor tendon rupture, tendinitis, or flexor irritation), whereas plate removal was a secondary outcome.Using soong grade 0 as a reference, the authors used univariable and multivariable logistic regression to calculate odds ratios (or) with 95% confidence intervals (ci) for flexor tendon issues and plate removal.It was stated acumed acu-loc 2 and acu-loc 1 was used.Flexor tendon rupture, tendinitis, flexor irritations, fixation failure, and plate removal were reported.Report 106 of 158 for the events of flexor tendon rupture, tendinitis, flexor irritations, fixation failure, and plate removal reported in this article.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Type of Device
PLATE, FIXATION, BONE
Manufacturer (Section D)
ACUMED, LLC
5885 ne cornelius pass road
hillsboro OR 97124
Manufacturer (Section G)
ACUMED LLC
5885 ne cornelius pass road
hillsboro OR 97124
Manufacturer Contact
ellie wood
5885 ne cornelius pass road
hillsboro, OR 97124
MDR Report Key16858140
MDR Text Key314440141
Report Number3025141-2023-00243
Device Sequence Number1
Product Code HRS
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Literature
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 04/26/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/02/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Date Manufacturer Received04/17/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-